Member Info for mulledwine

Simon Pryce, Group Chief Executive, commented: "The addition of these new locations represents another meaningful step in Signature Flight Support's expansion, and further strengthens our position as the leading North American and global FBO network. We are pleased to welcome these new businesses and their employees to the Group. We remain focused on taking advantage of the consolidation opportunities in the fragmented FBO market as part of the Group's broader growth strategy."

Signature Flight Support acquires three new locations BBA Aviation plc today announces that Signature Flight Support ("Signature") has recently acquired the assets of Azalea Aviation in Mobile, Alabama for an initial consideration of $22.0m with further payments of up to $5.3m over a 5 year period. Signature has also acquired 95% of Arrindell Aviation Services in St Maarten, Caribbean for a cash consideration of $7.8m. Azalea Aviation incorporates two sole source Fixed Base Operations ("FBOs"), the Mobile Air Center at the Mobile Regional Airport and the Downtown Air Center at the Mobile Downtown Airport with long lease terms of over 26 and 30 years respectively. This acquisition extends the Signature network into a key and growing business and general aviation location. Arrindell Aviation Services provides commercial and business and general aviation services at St. Maarten's Princess Juliana International Airport, with a 15 year remaining lease term. Princess Juliana International Airport is the second busiest airport in the Northeastern Caribbean. Following the acquisition of Tropical Aviation in Puerto Rico in July 2011, this represents an important extension of Signature's presence in key resort destinations in the Caribbean. These acquisitions are in line with the Group's growth strategy and bring the total number of North American FBOs to 65 and globally to 111.

http://www.investegate.co.uk/Article.aspx?id=201201040700109402U

CryptoLogic acquires licenses for InterCasino January 4, 2012 (Dublin, IRELAND) - CryptoLogic Limited, a developer of branded online betting games and Internet casino software, has acquired, for nominal consideration, the Maltese online gaming licenses for InterCasino from OIGE, a long-standing customer of the Company's fully hosted online casino platform. The transfer of the licenses has been cleared by the Maltese Lotteries & Gaming Authority.

http://www.investegate.co.uk/Article.aspx?id=201201040700109421U

Commenting on the transaction, Olivier Bohuon, Chief Executive Officer of Smith & Nephew, said: "In a single act we have given our existing Biologics business the resources to address longer-term development projects, retained access to the exciting area of orthobiologics, realised value for reinvestment in nearer-term opportunities, and freed up management resource to focus on driving efficiencies in established markets. Essex Woodlands are strong partners and the joint venture will benefit from their significant expertise in developing healthcare businesses." Bioventus will continue to market its current portfolio of products, including the EXOGEN◊ Ultrasound Bone Healing System and joint fluid therapy, and will seek to add further offerings. Smith & Nephew and Essex Woodlands are committed to investing a significant proportion of Bioventus' cash flow into R&D over the next five years. The business will continue to be headquartered in Durham, North Carolina and the existing management team, led by its current President, Mark Augusti, will transfer to Bioventus. Smith & Nephew will retain its research facility at York, UK. Marty Sutter, Founding Partner and Managing Director of Essex Woodlands said, "We see tremendous growth potential with this new venture as more patients discover how active products can help heal and treat joint and bone ailments without invasive surgery. Smith & Nephew has built an excellent business and we are excited about the prospect of working with the management team on the next phase of growth as it brings more active therapeutic products to market."

Smith & Nephew to form biologics joint venture with Essex Woodlands 4 January 2012 Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces today that it has, through its subsidiaries ("Smith & Nephew"), agreed to form a joint venture with Essex Woodlands (www.ewhv.com), a specialist healthcare growth equity and venture capital firm, to further develop its Biologics and Clinical Therapies division. The transaction is subject to obtaining required regulatory approvals and satisfaction of other customary conditions. The new entity, called Bioventus LLC ("Bioventus"), will be 51% owned by Essex Woodlands and 49% by Smith & Nephew. In addition to this shareholding, Smith & Nephew will receive approximately $98 million cash, which will be used to pay down debt, and a $160 million 5-year note from Bioventus. Smith & Nephew will transfer the vast majority of its US Biologics team and Clinical Therapies business to Bioventus and, for the time being, Smith & Nephew will continue to distribute Clinical Therapies products outside of the US.

http://www.investegate.co.uk/Article.aspx?id=201201040700119561U

Konstantinos Korletis, CEO of InternetQ commented: "The immense mobile marketing growth potential of the Southeast Asia region is undeniable. We have been looking forward to partnering with leading companies to bring cutting-edge mobile marketing technology to our clients in this market. Following the acquisition of i-POP Networks last July, we have been able to achieve a smooth integration of the two companies, given our excellent fit in terms of strategy, geography and portfolio. This has allowed us to combine our global expertise with the local company's key relationships with top mobile network operators and other leading companies; thus strengthen InternetQ's market position as the principal-choice mobile marketing technology provider for this region. "i-POP's management has been great to leverage on the reputation of InternetQ and has worked closely with the business development team of InternetQ to source new business and create increased sales pipeline opportunities for the group in rapidly developing markets. An important new step in strengthening our market positions is that, from now on, we will start presenting a single face to our customers, offering the combination of products and services of both companies under a single brand name, InternetQ. We believe that opportunities for our mobile technology business in Southeast Asia and other high-growth territories worldwide are greater today than at any other time. "

nternetQ Announces major mobile wins in the Southeast Asia Markets InternetQ Accelerates its business growth in Southeast Asia by unveiling major mobile marketing wins with five new mobile campaigns InternetQ plc (LSE-AIM: INTQ), one of the leading providers of mobile marketing and digital entertainment solutions announced today that, as expected, it has successfully executed important contracts and won new business with leading organizations in all regions of operation, tapping into the pan-Asian growth opportunities, through its wholly owned subsidiaries, i-POP Networks Ltd and INTQ Southeast Asia Ltd. Positioned to deliver growth, in the past six months Internet Q has increased connectivity by 125% to 124 mobile network operators, and coverage by 71% to 1.2 billion subscribers. InternetQ's new business pipeline remains strong, driven by the global demand for mobile value-added services. Recent customer wins include new clients like InMobi, as well as customers InternetQ has worked with in the past, namely Sun Cellular, and media powerhouses like FremantleMedia and Brand New Media. These recent wins make InternetQ a leading provider of mobile marketing solutions and a powerful business aggregator for all local mobile network operators in this fast growing region.

http://www.investegate.co.uk/Article.aspx?id=201201040700129378U

Vat Exclusive Sales Performance 1 August to 24 December NEXT Brand sales were up 3.1%, in line with the full year guidance range given in November of between 2.5% and 4.0%. The strong performance of NEXT Directory continued to compensate for slightly disappointing NEXT Retail store sales. Total stock for our End of Season Sale was up +10% on last year. The Sale has gone well and we expect final clearance rates to be slightly ahead of last year and our budget. Outlook for Full Year Profits We did not discount our products in the run up to Christmas and maintained operating margins. We continue to expect full year profit before tax on continuing business (see note) to be in line with our previous guidance. We are now narrowing our guidance range to £7m either side of £565m. This figure would represent an increase in profit of +4.0% on last year. NEXT's main financial objective is the delivery of sustainable long term growth in earnings per share, which have been further enhanced through cash generation and share buybacks. At a profit of £565m our EPS would be +11.3% ahead of last year.

http://www.investegate.co.uk/Article.aspx?id=201201040700109401U

ohn Beadle, CEO of PsiOxus, said: "Initiation of the toxicology study is an important milestone in the development of ColoAd1. PsiOxus can now progress the preparations for clinical trials of this promising therapeutic, knowing that a manufacturing solution for us is in place. We are very pleased with the close working relationship established with Ark Therapeutics, and we recognise their expertise in viral manufacture and the exceptional efforts they have made to fulfil our requirements." Martyn Williams, CEO of Ark commented: "We are delighted that our early success with ColoAd1 will enable the development of this exciting product to move forward as planned and we look forward to continuing to provide full support to our partner as their programme moves into the clinic. This further validation for Ark's ATOSUS process as a platform for (adeno)viral manufacture is very helpful as we continue discussions with other potential partners."

Early Success of Ark's Manufacturing Partnership with PsiOxus Initiation of Toxicology Study for PsiOxus's ColoAd1 Oncolytic Product London, UK - 4 January 2012, Ark Therapeutics Group plc ("Ark") and PsiOxus Therapeutics Ltd ("PsiOxus") are pleased to announce that the partnership announced on 12 September 2011 has successfully achieved its first milestone, by the timely manufacture of PsiOxus's ColoAd1 oncoloytic adenoviral product. As a result, PsiOxus has initiated final pre-clinical toxicology studies of this product, as scheduled, prior to the planned commencement of a Phase I study in 2012. The material was manufactured at Ark's facility in Kuopio, Finland, using Ark's proprietary suspension based single use process ("ATOSUS"), which was able to achieve the required product quality and demonstrate capability to exceed target process yields. ColoAd1 is under development by PsiOxus for the treatment of colorectal cancer.

http://www.investegate.co.uk/Article.aspx?id=201201040700109397U

I think its really only to do with the short term ( hopefully) depressed carbon prices

Camco International (CAO), the developer of clean energy products reported it has signed contracts to provide assessment and monitoring services for 37 energy efficiency programmes with China's largest cement producer. The group commented it views a favourable future for the carbon market in the medium and long term despite depressed current prices, which are set to impact the company's near term performance. With its stance under review, broker Singer Capital Markets believes Camco's strong cash position, of 11.3 million euros, will help it ride out the current period of uncertainty while strengthening its market position. The shares lost 0.5p to close at 6.125p.

Global Brands (GBR) confirmed it has demerged its existing pizza business into its Swiss subsidiary, Domino's Pizza Switzerland, transferring its shares to Global Brand shareholders. The demerger will result in investors holding equity in two distinct entities with entirely separate strategic characteristics and management teams. Global Brands will become an investing company, maintaining its AIM quotation, while Domino's Pizza Switzerland will continue to operate master franchise agreements across Switzerland, Luxembourg and Liechtenstein, and will stay in its private form. The shares surged on the news, by 0.125p to 0.55p.

Geoff Cooper, Chief Executive of Travis Perkins said: 'Toolstation offers great value and better reliability to customers who want to order and get materials in the way that suits them best - online, via their computer or mobile phone, or by a 'phone call to our call centre, or at our trade counters. With next day delivery, reserve and collection through our trade counters and full stocks at our branches, we help keep tradesmen working and productive. If it's in our catalogue, we've got it, and can get it to you - fast. Toolstation is a great addition to our consumer division and will add to our growth in market share and returns. Following this acquisition of the outstanding equity, we will look to further exploit Toolstation as part of our service to the trade and to DIY customers"